Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPAC II: Oral Moxifloxacin vs IV Ertapenem for Uncomplicated Appendicitis
NCT03236961Active, not recruiting
- Sponsor
- Turku University Hospital
- Start
- Apr 2017
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of moxifloxacin in acute appendicitis (2 arms), sponsored by Turku University Hospital. Primary endpoint: Treatment success at 1 year. Started Apr 2017; status: active, not recruiting.
02
Drugs
moxifloxacin
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT03236961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236961.